Topic
Clinical Trials
News
Clinical TrialsLaboratoryLife Sciences
Tekmira halts Ebola therapeutics trial
June 22, 2015 by Lab Canada Vancouver, BC & Doylestown, PA – Tekmira Pharmaceuticals Corporation announced today its Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed. In a statement, it said the endpoint indicated that continuing enrollment…
News
Clinical TrialsLaboratoryLife Sciences
New portal showcases Canadian clinical research capabilities
June 8, 2015 by Lab Canada Ottawa, ON – The Canadian Clinical Trials Coordinating Centre (CCTCC) has launched the Canadian Clinical Trials Asset Map, a pan-Canadian database showcasing Canada’s clinical research capacities. Intended to help Canada regain its position as a leading destination for clinical trials,…
News
Academic ResearchClinical TrialsCommercializationLaboratoryLife Sciences
Major private-academic partnership in biotech venture
December 10, 2014 by Lab Canada Toronto, ON – A new biotech company, Northern Biologics, has been officially unveiled by biotechnology incubator Blueline Bioscience in partnership with the University of Toronto (U of T) and University Health Network’s Princess Margaret Cancer Centre (UHN). The company will…
News
Academic ResearchClinical TrialsLaboratoryLife Sciences
Umbilical cord cells better at improving cardiac function
November 23, 2012 by Lab Canada Toronto, ON – Researchers at the University of Toronto, found that umbilical cord cells were 120% more effective than bone marrow cells in improving cardiac function after a heart attack, To stimulate tissue repair and control inflammation most stem cell…
News
BiotechnologyClinical TrialsLaboratoryLife SciencesResearch Results
Raman spectroscopy to diagnose skin cancers
September 17, 2012 by Lab Canada Vancouver, BC – After initial testing at the Skin Care Centre at Vancouver General Hospital (VGH) and at the BC Cancer Agency, beta units of Verisante Technology Aura are being placed in Calgary and Edmonton, with additional units to be…
News
Academic ResearchClinical TrialsLaboratoryLife Sciences
Common virus as potential cancer therapy
September 7, 2012 by Lab Canada Calgary, AB – The potential use of the reovirus as a possible treatment for multiple myeloma, a cancer that affects blood cells is being studied by researchers at the University of Calgary and Alberta Health Services’ Tom Baker Cancer Centre.…
News
Clinical TrialsGeneral Science & ResearchLaboratoryNew Facilities
LAB Research completes $12M expansion of Canadian site
December 7, 2006 by Lab Canada Laval, QC – Clinical contract research organization LAB Research says it has completed the expansion of its Canadian facility. The $12 million development is part of the company’s goal of enhancing its it says it will be able to better…
News
Clinical TrialsLaboratoryLife Sciences
Stroke program leads clinical stroke research for Canada
November 3, 2005 by Lab Canada Calgary, AB – Two new clinical research studies on stroke and the appointment of a leading stroke neurologist to the Heart and Stroke Foundation of Alberta, NWT & Nunavut, professorship in stroke research, have been announced by the University of…
News
Clinical TrialsGeneral Science & ResearchLaboratory
Potential anti-cancer compounds licensed for development
August 15, 2005 by Lab Canada Saskatoon, SK – The University of Saskatchewan and Mississauga-based drug development company YM BioSciences have signed a worldwide licensing agreement for the commercial development of new molecular compounds with potential to enhance cancer drug therapies. Under the agreement, YM BioSciences…
News
Clinical TrialsGeneral Science & ResearchLaboratory
Montreal component of Canadian heroin study to be conducted by the CHUM
June 6, 2005 by Lab Canada Montreal, QC – The CHUM (Centre hospitalier de l’Universit de Montral), in collaboration with CRAN (Centre de recherche et d’aide pour narcomanes), says it will soon launch the NAOMI project – a Canadian study that will test whether medically prescribed…
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences
Biotech firm begins development of pandemic influenza vaccine
January 19, 2005 by Lab Canada Vancouver, BC – ID Biomedical says it has begun development of an experimental (“mock”) vaccine against a strain of the influenza virus, H5N1, that experts believe could cause a deadly worldwide epidemic (pandemic) of influenza. The H5N1 strain is a…
News
Clinical TrialsLaboratoryLife Sciences
McGill researchers to test new leukemia drug
January 13, 2005 by Lab Canada Montreal, QC – Chronic myeloid leukemia (CML) is a malignant cancer of the blood that affects people of all ages. While treatment is available for most of these patients, approximately 20% of them do not respond to it. Researchers at…
News
Clinical TrialsLaboratoryNew Facilities
Drug-discovery company increases Phase I research capacities
December 21, 2004 by Lab Canada Montreal, QC – Drug-discovery company MDS Pharma Services says it has expanded and enhanced its facilities in St Laurent, QC, and Neptune, NJ, adding 108 beds for early clinical research. The expansion increases the facilities’ capacities to 304 and 128…
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences
Oncolytics Biotech appoints chief scientific officer
December 9, 2004 by Lab Canada Calgary, AB – Oncolytics Biotech has appointed Dr Matt Coffey as chief scientific officer. Dr Coffey was formerly the company’s vice president of product development. Oncolytics is developing a formulation of the human reovirus as a potential cancer therapeutic. It…
News
Clinical TrialsLaboratoryLife Sciences
LAB International to initiate phase II trial for GHRH
December 8, 2004 by Lab Canada Laval, AC – Drug development company LAB International says that, after completion of a successful dose-response trial, it has selected the first clinical indication for which it intends to evaluate the efficacy of its Growth Hormone Releasing Hormone (GHRH) analogue.…
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences
Pre-clinical cancer study receives NRC funding
December 6, 2004 by Lab Canada Edmonton, AB – CV Technologies says it is launching a pre-clinical study to investigate the effects of CVT-E002 in treating immune deficiency related cancers as part of its ongoing strategy to develop natural therapeuticals for disease prevention and health maintenance.…
News
Clinical TrialsLaboratoryLife Sciences
Stem cell mobilizer holds hope for potential use in allogeneic transplant for cancer patients
December 6, 2004 by Lab Canada Vancouver, BC – AnorMED has announced preliminary results on AMD3100, its lead drug candidate for stem cell transplantation, which support its potential use as a single agent to mobilize stem cells from healthy donors for allogeneic stem cell transplantation in…
News
Clinical TrialsLaboratoryLife Sciences
Anticancer drug receives patent
November 10, 2004 by Lab Canada Toronto, ON – Biopharmaceutical company Lorus Therapeutics, that specializes in the research, development and commercialization of pharmaceutical products and technologies for the management of cancer, says that its subsidiary, GeneSense Technologies, has been allowed a patent by the Canadian Patent…
News
Clinical TrialsGeneral Science & ResearchLaboratoryLife Sciences